FDA Adverse Event
Malfunction
Summary report: N
PRIMERDESIGN LTD COVID-19 GENESIG REAL-TIME PCR ASSAY
MDR report key: 11177282
·
Received January 14, 2021
Report
- Report Number
- MW5098828
- Event Type
- Malfunction
- Date Received
- January 14, 2021
- Date of Event
- December 31, 2020
- Report Date
- January 12, 2021
- Manufacturer
- PRIMER DESIGN LIMITED
- Product Code
- QJR
- Product Problem
- Yes
- Report Source
- Voluntary report
- Reporter Location
- MA, US
- Reporter Occupation
- OTHER HEALTH CARE PROFESSIONAL
Narratives
Description of Event or Problem · 1
[COVID-19 RT PCR DIAGNOSIS] TREATMENT UNDER EMERGENCY USE AUTHORIZATION (EUA): PRIMERDESIGN LTD COVID-19 REAL-TIME PCR ASSAY. THIS IS ONE OF 8 DIFFERENT INDIVIDUALS FROM A SINGLE LOCATION IN MA TESTED FIRST BY BINAX NOW (+), THEN PCR NEGATIVE (-) BY THIS TEST WITH THE ORF1AB TARGET, FOLLOWED BY RT-PCR (+) AT TWO TARGETS (N1 AND N2) PERFORMED BY A DIFFERENT LABORATORY (MA STATE PUBLIC HEALTH LABORATORY). ORIGINAL THOUGHT WAS THAT THE BINAX NOW HAD EXHIBITED A FALSE POSITIVE- EXCEPT THE SECOND SWAB FROM ALL 8 INDIVIDUALS WERE POSITIVE BY A DIFFERENT COVID-19 PCR TEST. FIVE OF THE 8 SAMPLES WERE WHOLE GENOME SEQUENCED BY THE MA SPHL. QUALITATIVE TEST PRESENT OR ABSENT FOR ONE COVID-19 GENETIC TARGET. FDA SAFETY REPORT ID # (B)(4).
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 71070 | PRIMERDESIGN LTD COVID-19 GENESIG REAL-TIME PCR ASSAY | REAGENTS, 2019-NOVEL CORONAVIRUS NUCLEIC | QJR | PRIMER DESIGN LIMITED |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 73 YR | Other |